table of content
1 Study Coverage
1.1 DNA Repair Drugs Product Introduction
1.2 Global DNA Repair Drugs Outlook 2017 VS 2022 VS 2028
1.2.1 Global DNA Repair Drugs Sales in US$ Million for the Year 2017-2028
1.2.2 Global DNA Repair Drugs Sales in Volume for the Year 2017-2028
1.3 United States DNA Repair Drugs Outlook 2017 VS 2022 VS 2028
1.3.1 United States DNA Repair Drugs Sales in US$ Million for the Year 2017-2028
1.3.2 United States DNA Repair Drugs Sales in Volume for the Year 2017-2028
1.4 DNA Repair Drugs Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.4.1 The Market Share of United States DNA Repair Drugs in Global, 2017 VS 2022 VS 2028
1.4.2 The Growth Rate of DNA Repair Drugs Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.5 DNA Repair Drugs Market Dynamics
1.5.1 DNA Repair Drugs Industry Trends
1.5.2 DNA Repair Drugs Market Drivers
1.5.3 DNA Repair Drugs Market Challenges
1.5.4 DNA Repair Drugs Market Restraints
1.6 Study Objectives
1.7 Years Considered
2 Market by Type
2.1 DNA Repair Drugs Market Segment by Type
2.1.1 PARP Inhibitors
2.1.2 Other
2.2 Global DNA Repair Drugs Market Size by Type
2.2.1 Global DNA Repair Drugs Sales in Value, by Type (2017, 2022 & 2028)
2.2.2 Global DNA Repair Drugs Sales in Volume, by Type (2017, 2022 & 2028)
2.2.3 Global DNA Repair Drugs Average Selling Price (ASP) by Type (2017, 2022 & 2028)
2.3 United States DNA Repair Drugs Market Size by Type
2.3.1 United States DNA Repair Drugs Sales in Value, by Type (2017, 2022 & 2028)
2.3.2 United States DNA Repair Drugs Sales in Volume, by Type (2017, 2022 & 2028)
2.3.3 United States DNA Repair Drugs Average Selling Price (ASP) by Type (2017, 2022 & 2028)
3 Market by Application
3.1 DNA Repair Drugs Market Segment by Application
3.1.1 Oncological
3.1.2 Stroke
3.2 Global DNA Repair Drugs Market Size by Application
3.2.1 Global DNA Repair Drugs Sales in Value, by Application (2017, 2022 & 2028)
3.2.2 Global DNA Repair Drugs Sales in Volume, by Application (2017, 2022 & 2028)
3.3.3 Global DNA Repair Drugs Average Selling Price (ASP) by Application (2017, 2022 & 2028)
3.3 United States DNA Repair Drugs Market Size by Application
3.3.1 United States DNA Repair Drugs Sales in Value, by Application (2017, 2022 & 2028)
3.3.2 United States DNA Repair Drugs Sales in Volume, by Application (2017, 2022 & 2028)
3.3.3 United States DNA Repair Drugs Average Selling Price (ASP) by Application (2017, 2022 & 2028)
4 Global DNA Repair Drugs Competitor Landscape by Company
4.1 Global DNA Repair Drugs Market Size by Company
4.1.1 Top Global DNA Repair Drugs Manufacturers Ranked by Revenue (2021)
4.1.2 Global DNA Repair Drugs Revenue by Manufacturer (2017-2022)
4.1.3 Global DNA Repair Drugs Sales by Manufacturer (2017-2022)
4.1.4 Global DNA Repair Drugs Price by Manufacturer (2017-2022)
4.2 Global DNA Repair Drugs Concentration Ratio (CR)
4.2.1 DNA Repair Drugs Market Concentration Ratio (CR) (2017-2022)
4.2.2 Global Top 5 and Top 10 Largest Manufacturers of DNA Repair Drugs in 2021
4.2.3 Global DNA Repair Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global DNA Repair Drugs Manufacturing Base Distribution, Product Type
4.3.1 Global DNA Repair Drugs Manufacturers, Headquarters and Distribution of Producing Region
4.3.2 Manufacturers DNA Repair Drugs Product Type
4.3.3 Date of International Manufacturers Enter into DNA Repair Drugs Market
4.4 Manufacturers Mergers & Acquisitions, Expansion Plans
4.5 United States DNA Repair Drugs Market Size by Company
4.5.1 Top DNA Repair Drugs Players in United States, Ranked by Revenue (2021)
4.5.2 United States DNA Repair Drugs Revenue by Players (2020, 2021 & 2022)
4.5.3 United States DNA Repair Drugs Sales by Players (2020, 2021 & 2022)
5 Global DNA Repair Drugs Market Size by Region
5.1 Global DNA Repair Drugs Market Size by Region: 2017 VS 2022 VS 2028
5.2 Global DNA Repair Drugs Market Size in Volume by Region (2017-2028)
5.2.1 Global DNA Repair Drugs Sales in Volume by Region: 2017-2022
5.2.2 Global DNA Repair Drugs Sales in Volume Forecast by Region (2023-2028)
5.3 Global DNA Repair Drugs Market Size in Value by Region (2017-2028)
5.3.1 Global DNA Repair Drugs Sales in Value by Region: 2017-2022
5.3.2 Global DNA Repair Drugs Sales in Value by Region: 2023-2028
6 Segment in Region Level & Country Level
6.1 North America
6.1.1 North America DNA Repair Drugs Market Size YoY Growth 2017-2028
6.1.2 North America DNA Repair Drugs Market Facts & Figures by Country (2017, 2022 & 2028)
6.1.3 U.S.
6.1.4 Canada
6.2 Asia-Pacific
6.2.1 Asia-Pacific DNA Repair Drugs Market Size YoY Growth 2017-2028
6.2.2 Asia-Pacific DNA Repair Drugs Market Facts & Figures by Region (2017, 2022 & 2028)
6.2.3 China
6.2.4 Japan
6.2.5 South Korea
6.2.6 India
6.2.7 Australia
6.2.8 Taiwan
6.2.9 Indonesia
6.2.10 Thailand
6.2.11 Malaysia
6.2.12 Philippines
6.3 Europe
6.3.1 Europe DNA Repair Drugs Market Size YoY Growth 2017-2028
6.3.2 Europe DNA Repair Drugs Market Facts & Figures by Country (2017, 2022 & 2028)
6.3.3 Germany
6.3.4 France
6.3.5 U.K.
6.3.6 Italy
6.3.7 Russia
6.4 Latin America
6.4.1 Latin America DNA Repair Drugs Market Size YoY Growth 2017-2028
6.4.2 Latin America DNA Repair Drugs Market Facts & Figures by Country (2017, 2022 & 2028)
6.4.3 Mexico
6.4.4 Brazil
6.4.5 Argentina
6.5 Middle East and Africa
6.5.1 Middle East and Africa DNA Repair Drugs Market Size YoY Growth 2017-2028
6.5.2 Middle East and Africa DNA Repair Drugs Market Facts & Figures by Country (2017, 2022 & 2028)
6.5.3 Turkey
6.5.4 Saudi Arabia
6.5.5 U.A.E
7 Company Profiles
7.1 4SC AG
7.1.1 4SC AG Corporation Information
7.1.2 4SC AG Description and Business Overview
7.1.3 4SC AG DNA Repair Drugs Sales, Revenue and Gross Margin (2017-2022)
7.1.4 4SC AG DNA Repair Drugs Products Offered
7.1.5 4SC AG Recent Development
7.2 ARCAGY/ GINECO GROUP
7.2.1 ARCAGY/ GINECO GROUP Corporation Information
7.2.2 ARCAGY/ GINECO GROUP Description and Business Overview
7.2.3 ARCAGY/ GINECO GROUP DNA Repair Drugs Sales, Revenue and Gross Margin (2017-2022)
7.2.4 ARCAGY/ GINECO GROUP DNA Repair Drugs Products Offered
7.2.5 ARCAGY/ GINECO GROUP Recent Development
7.3 Bristol Myers Squibb
7.3.1 Bristol Myers Squibb Corporation Information
7.3.2 Bristol Myers Squibb Description and Business Overview
7.3.3 Bristol Myers Squibb DNA Repair Drugs Sales, Revenue and Gross Margin (2017-2022)
7.3.4 Bristol Myers Squibb DNA Repair Drugs Products Offered
7.3.5 Bristol Myers Squibb Recent Development
7.4 British Columbia Cancer Agency
7.4.1 British Columbia Cancer Agency Corporation Information
7.4.2 British Columbia Cancer Agency Description and Business Overview
7.4.3 British Columbia Cancer Agency DNA Repair Drugs Sales, Revenue and Gross Margin (2017-2022)
7.4.4 British Columbia Cancer Agency DNA Repair Drugs Products Offered
7.4.5 British Columbia Cancer Agency Recent Development
7.5 Cambridge University Hospitals NHS Foundation Trust
7.5.1 Cambridge University Hospitals NHS Foundation Trust Corporation Information
7.5.2 Cambridge University Hospitals NHS Foundation Trust Description and Business Overview
7.5.3 Cambridge University Hospitals NHS Foundation Trust DNA Repair Drugs Sales, Revenue and Gross Margin (2017-2022)
7.5.4 Cambridge University Hospitals NHS Foundation Trust DNA Repair Drugs Products Offered
7.5.5 Cambridge University Hospitals NHS Foundation Trust Recent Development
7.6 Genentech
7.6.1 Genentech Corporation Information
7.6.2 Genentech Description and Business Overview
7.6.3 Genentech DNA Repair Drugs Sales, Revenue and Gross Margin (2017-2022)
7.6.4 Genentech DNA Repair Drugs Products Offered
7.6.5 Genentech Recent Development
7.7 Georgetown University
7.7.1 Georgetown University Corporation Information
7.7.2 Georgetown University Description and Business Overview
7.7.3 Georgetown University DNA Repair Drugs Sales, Revenue and Gross Margin (2017-2022)
7.7.4 Georgetown University DNA Repair Drugs Products Offered
7.7.5 Georgetown University Recent Development
7.8 German Breast Group
7.8.1 German Breast Group Corporation Information
7.8.2 German Breast Group Description and Business Overview
7.8.3 German Breast Group DNA Repair Drugs Sales, Revenue and Gross Margin (2017-2022)
7.8.4 German Breast Group DNA Repair Drugs Products Offered
7.8.5 German Breast Group Recent Development
7.9 GlaxoSmithKline
7.9.1 GlaxoSmithKline Corporation Information
7.9.2 GlaxoSmithKline Description and Business Overview
7.9.3 GlaxoSmithKline DNA Repair Drugs Sales, Revenue and Gross Margin (2017-2022)
7.9.4 GlaxoSmithKline DNA Repair Drugs Products Offered
7.9.5 GlaxoSmithKline Recent Development
7.10 Jiangsu Hengrui Medicine
7.10.1 Jiangsu Hengrui Medicine Corporation Information
7.10.2 Jiangsu Hengrui Medicine Description and Business Overview
7.10.3 Jiangsu Hengrui Medicine DNA Repair Drugs Sales, Revenue and Gross Margin (2017-2022)
7.10.4 Jiangsu Hengrui Medicine DNA Repair Drugs Products Offered
7.10.5 Jiangsu Hengrui Medicine Recent Development
7.11 Johnson & Johnson
7.11.1 Johnson & Johnson Corporation Information
7.11.2 Johnson & Johnson Description and Business Overview
7.11.3 Johnson & Johnson DNA Repair Drugs Sales, Revenue and Gross Margin (2017-2022)
7.11.4 Johnson & Johnson DNA Repair Drugs Products Offered
7.11.5 Johnson & Johnson Recent Development
7.12 Jonsson Comprehensive Cancer Center
7.12.1 Jonsson Comprehensive Cancer Center Corporation Information
7.12.2 Jonsson Comprehensive Cancer Center Description and Business Overview
7.12.3 Jonsson Comprehensive Cancer Center DNA Repair Drugs Sales, Revenue and Gross Margin (2017-2022)
7.12.4 Jonsson Comprehensive Cancer Center Products Offered
7.12.5 Jonsson Comprehensive Cancer Center Recent Development
7.13 Karyopharm Therapeutics
7.13.1 Karyopharm Therapeutics Corporation Information
7.13.2 Karyopharm Therapeutics Description and Business Overview
7.13.3 Karyopharm Therapeutics DNA Repair Drugs Sales, Revenue and Gross Margin (2017-2022)
7.13.4 Karyopharm Therapeutics Products Offered
7.13.5 Karyopharm Therapeutics Recent Development
7.14 KuDOS Pharmaceuticals
7.14.1 KuDOS Pharmaceuticals Corporation Information
7.14.2 KuDOS Pharmaceuticals Description and Business Overview
7.14.3 KuDOS Pharmaceuticals DNA Repair Drugs Sales, Revenue and Gross Margin (2017-2022)
7.14.4 KuDOS Pharmaceuticals Products Offered
7.14.5 KuDOS Pharmaceuticals Recent Development
7.15 National Health Service
7.15.1 National Health Service Corporation Information
7.15.2 National Health Service Description and Business Overview
7.15.3 National Health Service DNA Repair Drugs Sales, Revenue and Gross Margin (2017-2022)
7.15.4 National Health Service Products Offered
7.15.5 National Health Service Recent Development
7.16 National Institutes of Health
7.16.1 National Institutes of Health Corporation Information
7.16.2 National Institutes of Health Description and Business Overview
7.16.3 National Institutes of Health DNA Repair Drugs Sales, Revenue and Gross Margin (2017-2022)
7.16.4 National Institutes of Health Products Offered
7.16.5 National Institutes of Health Recent Development
7.17 Tesaro
7.17.1 Tesaro Corporation Information
7.17.2 Tesaro Description and Business Overview
7.17.3 Tesaro DNA Repair Drugs Sales, Revenue and Gross Margin (2017-2022)
7.17.4 Tesaro Products Offered
7.17.5 Tesaro Recent Development
8 Industry Chain and Sales Channels Analysis
8.1 DNA Repair Drugs Industry Chain Analysis
8.2 DNA Repair Drugs Key Raw Materials
8.2.1 Key Raw Materials
8.2.2 DNA Repair Drugs Distributors
8.3 DNA Repair Drugs Production Mode & Process
8.4 DNA Repair Drugs Sales and Marketing
8.4.1 DNA Repair Drugs Sales Channels
8.4.2 DNA Repair Drugs Distributors
8.5 DNA Repair Drugs Customers
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
